Quarterly turnover was £6.47bn, down from restated £6.64bn for the same period last year.
GSK delivered core EPS of 26.9pence and dividend of 18pence for the first quarter of 2013.
The company expects to deliver full-year earnings per share growth of 3-4% at constant exchange rates.